781 related articles for article (PubMed ID: 20952687)
1. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Brunstein CG; Miller JS; Cao Q; McKenna DH; Hippen KL; Curtsinger J; Defor T; Levine BL; June CH; Rubinstein P; McGlave PB; Blazar BR; Wagner JE
Blood; 2011 Jan; 117(3):1061-70. PubMed ID: 20952687
[TBL] [Abstract][Full Text] [Related]
2. Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic Cells.
Vanichapol T; Pongsakul N; Srisala S; Apiwattanakul N; Chutipongtanate S; Hongeng S
J Immunother; 2019 May; 42(4):110-118. PubMed ID: 30921263
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.
Brunstein CG; Miller JS; McKenna DH; Hippen KL; DeFor TE; Sumstad D; Curtsinger J; Verneris MR; MacMillan ML; Levine BL; Riley JL; June CH; Le C; Weisdorf DJ; McGlave PB; Blazar BR; Wagner JE
Blood; 2016 Feb; 127(8):1044-51. PubMed ID: 26563133
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
5. Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.
McKenna DH; Sumstad D; Kadidlo DM; Batdorf B; Lord CJ; Merkel SC; Koellner CM; Curtsinger JM; June CH; Riley JL; Levine BL; Miller JS; Brunstein CG; Wagner JE; Blazar BR; Hippen KL
Cytotherapy; 2017 Feb; 19(2):250-262. PubMed ID: 27887864
[TBL] [Abstract][Full Text] [Related]
6. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
[TBL] [Abstract][Full Text] [Related]
7. Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
Parmar S; Liu X; Tung SS; Robinson SN; Rodriguez G; Cooper LJ; Yang H; Shah N; Yang H; Konopleva M; Molldrem JJ; Garcia-Manero G; Najjar A; Yvon E; McNiece I; Rezvani K; Savoldo B; Bollard CM; Shpall EJ
Cytotherapy; 2014 Jan; 16(1):90-100. PubMed ID: 24480547
[TBL] [Abstract][Full Text] [Related]
8. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
Porter SB; Liu B; Rogosheske J; Levine BL; June CH; Kohl VK; Wagner JE; Miller JS; Blazar BR
Transplantation; 2006 Jul; 82(1):23-9. PubMed ID: 16861937
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation.
Nikiforow S; Kim HT; Daley H; Reynolds C; Jones KT; Armand P; Ho VT; Alyea EP; Cutler CS; Ritz J; Antin JH; Soiffer RJ; Koreth J
Haematologica; 2016 Oct; 101(10):1251-1259. PubMed ID: 27354021
[TBL] [Abstract][Full Text] [Related]
10. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G
J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748
[TBL] [Abstract][Full Text] [Related]
12. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
Lee CC; Lin SJ; Cheng PJ; Kuo ML
Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176
[TBL] [Abstract][Full Text] [Related]
13. Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells.
Lin SJ; Lu CH; Yan DC; Lee PT; Hsiao HS; Kuo ML
Immunol Res; 2014 Oct; 60(1):105-11. PubMed ID: 24515612
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
Theil A; Tuve S; Oelschlägel U; Maiwald A; Döhler D; Oßmann D; Zenkel A; Wilhelm C; Middeke JM; Shayegi N; Trautmann-Grill K; von Bonin M; Platzbecker U; Ehninger G; Bonifacio E; Bornhäuser M
Cytotherapy; 2015 Apr; 17(4):473-86. PubMed ID: 25573333
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
Robinson KL; Ayello J; Hughes R; van de Ven C; Issitt L; Kurtzberg J; Cairo MS
Exp Hematol; 2002 Mar; 30(3):245-51. PubMed ID: 11882362
[TBL] [Abstract][Full Text] [Related]
16. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.
Horwitz ME; Chao NJ; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McDonald C; Waters-Pick B; Stiff P; Wease S; Peled A; Snyder D; Cohen EG; Shoham H; Landau E; Friend E; Peleg I; Aschengrau D; Yackoubov D; Kurtzberg J; Peled T
J Clin Invest; 2014 Jul; 124(7):3121-8. PubMed ID: 24911148
[TBL] [Abstract][Full Text] [Related]
17. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
18. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
[TBL] [Abstract][Full Text] [Related]
19. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
[TBL] [Abstract][Full Text] [Related]
20. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients.
Roschupkina T; Juliusson G
Cytometry B Clin Cytom; 2018 Mar; 94(2):264-269. PubMed ID: 27479496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
